Le Lézard
Classified in: Health
Subject: ACC

Navamedic: Annual report 2021


OSLO, Norway, April 29, 2022 /PRNewswire/ -- Navamedic ASA (OSE: NAVA) publishes its annual report for 2021. The report is attached and available on navamedic.com/investors. Additionally, the company's Annual Report in European Single Electronic Format (ESEF) is attached, please refer to the zip-file.

For further information, please contact:

Kathrine Gamborg Andreassen
CEO
Navamedic
Mobile: +47 951 78 680
E-mail: kathrine@navamedic.com

Lars Hjarrand
CFO
Navamedic
Mobile: +47 917 62 842
E-mail: lars.hjarrand@navamedic.com

Navamedic ASA is a Nordic pharma company and reliable provider of high-quality products, delivered to hospitals and through pharmacies, meeting the specific needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/navamedic-asa/r/navamedic--annual-report-2021,c3556510

The following files are available for download:

https://mb.cision.com/Main/17619/3556510/1571604.pdf

Navamedic ASA Annual report 2021

https://mb.cision.com/Main/17619/3556510/1571607.zip

NavamedicASA-2021-12-31-en.zip


These press releases may also interest you

13 aoû 2022
At least 5% of Americans suffer from chronic low back pain. [1] Over $630 billion is spent annually on costs to society [2], and chiropractic care is essential in managed post-surgical spinal pain [3] and scoliosis [4]. To prepare clinicians...

13 aoû 2022
Ziegler is pleased to announce the successful closing of Shenandoah Valley Westminster-Canterbury's $71,000,000 Series 2022A and 2022B Bonds for the Senior Living Finance Practice. Shenandoah Valley Westminster-Canterbury (SVWC) is a Virginia...

12 aoû 2022
The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of LifeStance Health Group, Inc. common stock issued in connection with LifeStance Health's June 10, 2021 initial...

12 aoû 2022
An arbitrator issued a decision today in a dispute between Daiichi Sankyo Company, Ltd. and Seagen, Inc., denying all claims made by Seagen. Specifically, Daiichi Sankyo retains all patent rights to its antibody drug conjugate (ADC) technology and...

12 aoû 2022
Core One Labs Inc. , , (the "Company" or "Core One") is pleased to announce that scientists at its wholly-owned subsidiary Awakened Biosciences Inc. ("Awakened") have successfully produced a precursor that can be...

12 aoû 2022
Following the passage of the Inflation Reduction Act, Peter L. Saltonstall, President and CEO, the National Organization for Rare Disorders (NORD), issued the following statement:...



News published on 29 april 2022 at 02:22 and distributed by: